2gwu: Difference between revisions
From Proteopedia
Jump to navigationJump to search
m Protected "2gwu" [edit=sysop:move=sysop] |
No edit summary |
||
| (6 intermediate revisions by the same user not shown) | |||
| Line 1: | Line 1: | ||
{{Theoretical_model}} | {{Theoretical_model}} | ||
[[ | ==STRUCTURE MODEL OF HUMAN ARYLAMINE N-ACETYLTRANSFERASE 1== | ||
<StructureSection load='2gwu' size='340' side='right'caption='[[2gwu]]' scene=''> | |||
== Structural highlights == | |||
<table><tr><td colspan='2'>For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=2GWU FirstGlance]. <br> | |||
</td></tr><tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=2gwu FirstGlance], [https://www.ebi.ac.uk/pdbsum/2gwu PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=2gwu ProSAT]</span></td></tr> | |||
</table> | |||
<div style="background-color:#fffaf0;"> | |||
== Publication Abstract from PubMed == | |||
Arylamine N-acetyltransferases (NATs) catalyze the acetylation of arylamines, a key step in the detoxification of many carcinogens. The determinants of NAT substrate specificity are not known, yet this knowledge is required to understand why NAT enzymes acetylate some arylamines, but not others. Here, we use NMR spectroscopy and homology modeling to reveal the structural determinants of arylamine acetylation by NATs. In particular, by using chemical shift perturbation analysis, we have identified residues that play a critical role in substrate binding and catalysis. This study reveals why human NAT1 acetylates the sunscreen additive p-aminobenzoic acid and tobacco smoke carcinogen 4-aminobiphenyl, but not o-toluidine and other arylamines linked to bladder cancer. Our results represent an important step toward predicting whether arylamines present in new products can be detoxified by mammalian NATs. | |||
NMR-based model reveals the structural determinants of mammalian arylamine N-acetyltransferase substrate specificity.,Zhang N, Liu L, Liu F, Wagner CR, Hanna PE, Walters KJ J Mol Biol. 2006 Oct 13;363(1):188-200. Epub 2006 Aug 15. PMID:16959263<ref>PMID:16959263</ref> | |||
== | From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.<br> | ||
</div> | |||
<div class="pdbe-citations 2gwu" style="background-color:#fffaf0;"></div> | |||
== References == | |||
== | <references/> | ||
< | __TOC__ | ||
</StructureSection> | |||
[[Category: Theoretical Model]] | |||
[[Category: Large Structures]] | |||
[[Category: Hanna, P E]] | [[Category: Hanna, P E]] | ||
[[Category: Liu, F]] | [[Category: Liu, F]] | ||
Latest revision as of 11:02, 5 January 2022
 |
STRUCTURE MODEL OF HUMAN ARYLAMINE N-ACETYLTRANSFERASE 1
| ||||||||||||
